Recurrent Urinary Tract Infection
37
5
11
15
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
5.4%
2 terminated out of 37 trials
88.2%
+1.7% vs benchmark
32%
12 trials in Phase 3/4
33%
5 of 15 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 15 completed trials
Clinical Trials (37)
Study to Evaluate the Efficacy of Lactobacillus Crispatus M247 in the Prevention and Treatment of Recurrent Urinary Tract Infections
Effect of a Probiotic on the Urinary Tract Microbiota of Participants With Recurrent Urinary Tract Infection.
Preventing Recurrent UTI With Vaginal Estrogen
Adherence to Vaginal Estrogen Therapy in Hypoestrogenic Women With Recurrent Urinary Tract Infections
Chlorhexidine Lavage for Recurrent Urinary Tract Infection
Preference of Women With Recurrent Urinary Tract Infection for Vaginal Estradiol Tablet vs Cream
Prevention of Recurrent UTI Using Vaginal Testosterone Versus Placebo Placebo
A Trial of D-mannose for the Prophylaxis of Recurrent Urinary Tract Infections
EHR-integrated rUTI Texting Platform
Periurethral vs Intravaginal Estrogen for Prevention of Recurrent Urinary Tract Infections
RCT Comparing Intravaginal Laser Therapy to Sham in Post-menopausal Women with Recurrent Urinary Tract Infections
Gag Therapy for Recurrent Urinary Tract Infection Assessing Comparability to International Nitrofurantoin Gold Standard Study
The Effect of Methenamine Hippurate to Reduce Antibiotic Prescribing in Elderly Women With Recurrent UTI
Real-life Clinical Experience With Ialuadapter Study
Recurrent Urinary Tract Infections and the Microbiome
Phage Therapy for the Treatment of Urinary Tract Infection
Phase II Clinical Trial of Vitamin D3 for Reducing Recurrence of Recurrent Lower Urinary Tract Infections
Expanded Access Program Using Uromune for Patients With Recurrent Urinary Tract Infections (rUTI)
Faecal Microbiota Transplantation as Means of Preventing Recurrent Urinary Tract Infections
Patient Satisfaction and Long-term Safety of Intravesical Aminoglycoside Instillations in UTI Prevention